Armistice Capital, LLC Ironwood Pharmaceuticals Inc Transaction History
Armistice Capital, LLC
- $7.08 Billion
- Q4 2024
A detailed history of Armistice Capital, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 9,468,000 shares of IRWD stock, worth $18 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
9,468,000
Previous 8,200,000
15.46%
Holding current value
$18 Million
Previous $33.7 Million
24.45%
% of portfolio
0.59%
Previous 0.56%
Shares
6 transactions
Others Institutions Holding IRWD
# of Institutions
243Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$43.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$37.1 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$31.1 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$22.3 Million0.13% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.07MShares$17.2 Million0.06% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $291M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...